Bibliography

Found 374 results
Filters: Keyword is Humans  [Clear All Filters]
2015
Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915
Wüthrich C, Batson S, Koralnik IJ. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 ;74(8):791-803.
Fields JAdam, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res. 2015 ;13(1):43-54.
Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, et al. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Clin Infect Dis. 2015 ;61(9):1476-84.
Cserhati MF, Pandey S, Beaudoin JJ, Baccaglini L, Guda C, Fox HS. The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies. Database (Oxford). 2015 ;2015:bav074.
Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, J Atkinson H, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 ;60(3):473-80.
Morgan EE, Iudicello JE, Cattie JE, Blackstone K, Grant I, Woods SPaul. Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS Behav. 2015 ;19(1):166-77.
Kim WJ, Zekas E, Lodge R, Susan-Resiga D, Marcinkiewicz E, Essalmani R, Mihara K, Ramachandran R, Asahchop E, Gelman B, et al. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder. Mol Cell Biol. 2015 ;35(21):3684-700.
Robinson-Papp JS, Sharma S, Dhadwal N, Simpson DM, Morgello S. Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015 ;51(1):56-64.
Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping L-H, Schnell G, Sturdevant CB, Kincer LP, Mallewa M, et al. Phenotypic Correlates of HIV-1 Macrophage Tropism. J Virol. 2015 ;89(22):11294-311.
Fazeli PL, Marquine MJ, Dufour C, Henry BL, Montoya JL, Gouaux B, Moore RC, Letendre S, Woods SPaul, Grant I, et al. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav. 2015 ;19(8):1470-7.
Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, et al. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 ;69(1):29-35.
Malvar J, Vaida F, Sanders CFitzsimons, J Atkinson H, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, et al. Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain. 2015 ;156(4):731-739.
Fellows RP, Spahr NA, Byrd DA, Mindt MRivera, Morgello S. Psychological trauma exposure and co-morbid psychopathologies in HIV+Men and Women. Psychiatry Res. 2015 ;230(3):770-6.
Hobkirk AL, Starosta AJ, De Leo JA, Marra CM, Heaton RK, Earleywine M. Psychometric validation of the BDI-II among HIV-positive CHARTER study participants. Psychol Assess. 2015 ;27(2):457-66.
Olsen JP, Fellows RP, Rivera-Mindt M, Morgello S, Byrd DA. Reading Ability as an Estimator of Premorbid Intelligence: Does It Remain Stable Among Ethnically Diverse HIV+ Adults?. Clin Neuropsychol. 2015 ;29(7):1034-52.
Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore DJ, Heizerling K, et al. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 ;29(12):1483-91.
Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, Miranda C, Morgello S, Mindt MRivera. Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort. Clin Neuropsychol. 2015 ;29(2):232-54.
2014
Mindt MRivera, Miranda C, Arentoft A, Byrd D, Monzones J, Fuentes A, Arias F, Rentería MArce, Rosario A, Morgello S. Aging and HIV/AIDS: neurocognitive implications for older HIV-positive Latina/o adults. Behav Med. 2014 ;40(3):116-23.
Lucas C-H, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett. 2014 ;558:97-102.
Vartak-Sharma N, Gelman BB, Joshi C, Borgamann K, Ghorpade A. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression. J Biol Chem. 2014 ;289(28):19599-612.
Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res. 2014 ;12(2):97-110.
Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, et al. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014 ;20(6):603-11.
Kim JY, Singer EJ, Bonelli L, Klausner JD. A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease. J Int Assoc Provid AIDS Care. 2014 ;13(3):196-9.

Pages